Anti-EphA3 Antibody (Ifabotuzumab)
Catalog No.
F2070
Anti-EphA3 Antibody (Ifabotuzumab)
Featured Products
Ifabotuzumab (KB004) is an IgG1κ antibody (KD=610 pM) targeting EphA3. Ifabotuzumab can induce tumor cell apoptosis and activate antibody-dependent cell-mediated cytotoxicity (ADCC), destroying tumor vasculature. Ifabotuzumab can reduce human idiopathic pulmonary fibrosis (IPF) CCR10+ cells and improve lung fibrosis.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.4 kDa
Dry ice
1234137-51-9
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
KB004, IIIA4, fibatuzumab
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P29320
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
EphA3
Please avoid freeze-thaw cycles.